Engineered phage with antibacterial CRISPR-Cas selectively reduce E. coli burden in mice.
Nat Biotechnol
; 42(2): 265-274, 2024 Feb.
Article
in En
| MEDLINE
| ID: mdl-37142704
Full text:
1
Database:
MEDLINE
Main subject:
Bacteriophages
/
Escherichia coli
Limits:
Animals
/
Humans
Language:
En
Journal:
Nat Biotechnol
Journal subject:
BIOTECNOLOGIA
Year:
2024
Type:
Article
Affiliation country:
Denmark